These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways. Zhang Y, Jiang Q, Dudus L, Yankaskas JR, Engelhardt JF. Hum Gene Ther; 1998 Mar 20; 9(5):635-48. PubMed ID: 9551612 [Abstract] [Full Text] [Related]
6. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hay JG, McElvaney NG, Herena J, Crystal RG. Hum Gene Ther; 1995 Nov 20; 6(11):1487-96. PubMed ID: 8573621 [Abstract] [Full Text] [Related]
7. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice. Cmielewski P, Donnelley M, Parsons DW. J Gene Med; 2014 Nov 20; 16(9-10):291-9. PubMed ID: 25130650 [Abstract] [Full Text] [Related]
9. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR. N Engl J Med; 1995 Sep 28; 333(13):823-31. PubMed ID: 7544439 [Abstract] [Full Text] [Related]
10. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Knowles MR, Paradiso AM, Boucher RC. Hum Gene Ther; 1995 Apr 28; 6(4):445-55. PubMed ID: 7542031 [Abstract] [Full Text] [Related]
11. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy. Flotte TR. Curr Opin Mol Ther; 2001 Oct 28; 3(5):497-502. PubMed ID: 11699895 [Abstract] [Full Text] [Related]
15. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Ferrari S, Griesenbach U, Iida A, Farley R, Wright AM, Zhu J, Munkonge FM, Smith SN, You J, Ban H, Inoue M, Chan M, Singh C, Verdon B, Argent BE, Wainwright B, Jeffery PK, Geddes DM, Porteous DJ, Hyde SC, Gray MA, Hasegawa M, Alton EW. Gene Ther; 2007 Oct 28; 14(19):1371-9. PubMed ID: 17597790 [Abstract] [Full Text] [Related]
16. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice. Jiang C, Akita GY, Colledge WH, Ratcliff RA, Evans MJ, Hehir KM, St George JA, Wadsworth SC, Cheng SH. Hum Gene Ther; 1997 Apr 10; 8(6):671-80. PubMed ID: 9113507 [Abstract] [Full Text] [Related]
18. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis. Knowles MR, Noone PG, Hohneker K, Johnson LG, Boucher RC, Efthimiou J, Crawford C, Brown R, Schwartzbach C, Pearlman R. Hum Gene Ther; 1998 Jan 20; 9(2):249-69. PubMed ID: 9472784 [Abstract] [Full Text] [Related]
19. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Dekkers JF, Berkers G, Kruisselbrink E, Vonk A, de Jonge HR, Janssens HM, Bronsveld I, van de Graaf EA, Nieuwenhuis EE, Houwen RH, Vleggaar FP, Escher JC, de Rijke YB, Majoor CJ, Heijerman HG, de Winter-de Groot KM, Clevers H, van der Ent CK, Beekman JM. Sci Transl Med; 2016 Jun 22; 8(344):344ra84. PubMed ID: 27334259 [Abstract] [Full Text] [Related]